Table 8 Demographic and clinical data for patients with myomas ≤20 mm
| Sub Group A1 (IBS®) | Sub Group B1 (Versapoint®) |
|---|---|---|
n (%) | 7 (14) | 3 (6.1) |
Size (mm)a | 15 (10–20) 15 (4.47) | 20 (10–20) 17.5 (4.33) |
Age (years)b | 51 (44–74) | 48 (43–52) |
Parity (%) | ||
Nulliparous | 3 (42.8) | 1 (33.3) |
Multiparous | 4 (57.2) | 2 (66.6) |
Menopause (%) | 2 (28.6) | 1 (33.3) |
Symptoms (%) | ||
None | 1 (14.3) | 2 (66.6) |
Menorrhagia | 4 (57.2) | 1 (33.3) |
Anaemia | 1 (14.3) | 1 (33.3) |
Post Menop. AUB | 1 (14.3) | 0 (0) |
Pelvic Pain | 0 (0) | 0 (0) |
Infertility | 0 (0) | 0 (0) |
Myomas’ Type | ||
G0 | 0 | 0 |
G1 | 4 | 3 |
G2 | 3 | 0 |
Number of procedures (%) | ||
Single step | 7 (100) | 3 (100) |
Two steps | (0) | 0 (0) |
Residual Myoma | (0) | 0 (0) |
Complications (%) | (0) | 0 (0) |